Drug Type Small molecule drug, Diagnostic radiopharmaceuticals |
Synonyms BR-02, [18F]BF3 BPA, [18F]BF3-BPA + [2] |
Target- |
Mechanism PET imaging(Positron-emission tomography enhancers) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Brain Cancer | Phase 1 | CN | 17 Apr 2024 | |
Brain Cancer | Phase 1 | CN | 17 Apr 2024 |